This activity has been designed to meet the educational needs of physician assistants and nurse practitioners in primary care who volunteer to provide first aid and identify life-threatening emergencies among participants in running and walking marathons.
Original Release Date: May 2010
Expiration Date: May 31, 2011
Estimated Time to Complete this Activity: 1 hour
Medium: Printed journal and online CE/CME
The primary objective of this educational initiative is to provide clinicians in primary care with the most up-to-date information regarding assessment of marathon runners and walkers who require medical attention during or after an event.
After completing this activity, the participant should be better able to:
Randy D. Danielsen, PhD, PA-C, DFAAPA, is Dean and Professor at the Arizona School of Health Sciences, A. T. Still University in Mesa, PA Editor-in-Chief of Clinician Reviews, and Medical Director for the P. F. Chang’s Arizona Rock ’n’ Roll Marathon and “½ Marathon.” Lewis G. Maharam, MD, FACSM, is Chairman of the International Marathon Medical Directors Association and Medical Director for all of the Competitor Group Rock ’n’ Roll events. Eric L. Sauers, PhD, ATC, FNATA, is Associate Professor and Chair of the Department of Interdisciplinary Health Sciences at A. T. Still University, and an Assistant Medical Director for the P. F. Chang’s Arizona Rock ’n’ Roll Marathon and “½ Marathon.”
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of May 2010. Participants may submit the self-assessment at any time during that period.
This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
Successful completion of the self-assessment is required to earn Category I CME credit. Successful completion is defined as a cumulative score of at least 70% correct.
This program has been approved by the Nurse Practitioner Association New York State (The NPA) for 1.0 contact hour.
DISCLOSURE OF CONFLICTS OF INTEREST
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Randy D. Danielsen, PhD, PA-C, DFAAPA, Lewis G. Maharam, MD, FACSM, and Eric L. Sauers, PhD, ATC, reported no significant financial relationship with any commercial entity related to this activity.
METHOD OF PARTICIPATION
The fee for participating and receiving CME credit for this activity is $10.00. During the period May 2010 through May 31, 2011, participants must:
If you have any questions, e-mail CR.firstname.lastname@example.org. Upon successful completion of an online posttest, with a score of 70% of better, and the completion of the online activity evaluation form, a statement of credit will be made available immediately.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AAPA, The NPA, and Quadrant HealthCom Inc. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of AAPA, The NPA, or Quadrant HealthCom Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and the possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.